Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,791 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,315 · Balance 8,791 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.78 · Expires 2036-06-08 | Direct | 5,853 |
Reported balance
After 2026-06-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-09 · Grant · Acquired 5,853 · Balance 5,853 F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date February 05, 2024 · Filed February 07, 2024
Section 16 reporting ended · disclosed 2024-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,005 |
Ending reported balance
After 2024-02-05 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-02-05 · Tax withholding · Disposed 2,208 · Balance 25,524 Row 2 · 2024-02-05 · Tax withholding · Disposed 1,077 · Balance 24,447 Row 3 · 2024-02-05 · Tax withholding · Disposed 213 · Balance 24,234 Row 4 · 2024-02-05 · Sale · Disposed 300 · Balance 23,934 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 5 · 2024-02-05 · Sale · Disposed 1,703 · Balance 22,231 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 6 · 2024-02-05 · Sale · Disposed 1,226 · Balance 21,005 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
Filing footnotes · ownership attribution and instrument terms
F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2022 Filed Aug 24, 2022 00:31 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,100 | $292.21 | $321,431.00 |
DisclosureSEC source: 0001209191-22-047276 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,938 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F2 · price: All reported securities were sold at a price of $292.21. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 00:31 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,100 | $17.00 | $18,700.00 |
DisclosureSEC source: 0001209191-22-047276 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 00:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 240 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-042938 · doc4.xml · derivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55 Underlying: Common Stock · 240 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F4 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 00:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 1,110 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042938 · doc4.xml · derivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,880 Underlying: Common Stock · 1,110 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F3 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 00:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,350 | $207.09 | $279,571.50 |
DisclosureSEC source: 0001209191-22-042938 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,938 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F2 · price: All reported securities were sold at a price of $207.09. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 00:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 240 | $4.03 | $966.24 |
DisclosureSEC source: 0001209191-22-042938 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 00:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,110 | $17.00 | $18,870.00 |
DisclosureSEC source: 0001209191-22-042938 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:03 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 240 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-038786 · doc4.xml · derivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295 Underlying: Common Stock · 240 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F4 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:03 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 1,110 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038786 · doc4.xml · derivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,990 Underlying: Common Stock · 1,110 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F3 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:03 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,350 | $161.40 | $217,890.00 |
DisclosureSEC source: 0001209191-22-038786 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,938 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $160.70 to $161.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:03 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 240 | $4.03 | $966.24 |
DisclosureSEC source: 0001209191-22-038786 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:03 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,110 | $17.00 | $18,870.00 |
DisclosureSEC source: 0001209191-22-038786 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| May 20, 2022 Filed May 27, 2022 20:40 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 1,110 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032577 · doc4.xml · derivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,100 Underlying: Common Stock · 1,110 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F4 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| May 20, 2022 Filed May 27, 2022 20:40 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 240 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-032577 · doc4.xml · derivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 Underlying: Common Stock · 240 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F3 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| May 20, 2022 Filed May 27, 2022 20:40 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,350 | $161.38 | $217,863.00 |
DisclosureSEC source: 0001209191-22-032577 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,048 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F2 · price: All reported securities were sold at a price of $161.38. Read SEC document |
| May 20, 2022 Filed May 27, 2022 20:40 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,110 | $17.00 | $18,870.00 |
DisclosureSEC source: 0001209191-22-032577 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| May 20, 2022 Filed May 27, 2022 20:40 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 240 | $4.03 | $966.24 |
DisclosureSEC source: 0001209191-22-032577 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 2,220 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · derivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,210 Underlying: Common Stock · 2,220 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F8 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 480 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775 Underlying: Common Stock · 480 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 420 | $206.31 | $86,650.20 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,938 F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.78 to $206.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 400 | $204.42 | $81,768.00 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,358 F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.05 to $204.88. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,000 | $203.01 | $203,010.00 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,758 F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $202.55 to $203.47. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,871 | $197.20 | $368,961.20 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,758 F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.06 to $198.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 2,220 | $17.00 | $37,740.00 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 480 | $4.03 | $1,934.40 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 1,009 | $206.28 | $208,136.52 |
DisclosureSEC source: 0001209191-22-025048 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,929 F1 · price: All reported securities were sold at a price of $206.28. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 2,762 | $158.76 | $438,495.12 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,938 Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 3,567 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,430 Underlying: Common Stock · 3,567 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48th of the stock options vest monthly beginning on 4/16/2019, subject to the continued service to the Issuer by the Reporting Person on each vesting date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 254 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · derivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255 Underlying: Common Stock · 254 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48th of the stock options vest monthly beginning on 8/19/2018, subject to the continued service to the Issuer by the Reporting Person on each vesting date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 2,800 | $150.55 | $421,540.00 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,700 Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 3,907 | $140.57 | $549,206.99 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 3,821 | $140.43 | $536,583.03 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,407 Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 3,567 | $17.00 | $60,639.00 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:19 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 254 | $4.03 | $1,023.62 |
DisclosureSEC source: 0001209191-22-012835 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 01:43 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 1,460 | $157.02 | $229,249.20 |
DisclosureSEC source: 0001209191-22-010012 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,407 Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 01:46 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 1,460 | $157.02 | $229,249.20 |
DisclosureSEC source: 0001209191-22-010020 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,407 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 8,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006801 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,396 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:32 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Tax withholdingCommon Stock | 1,471 | $155.03 | $228,049.13 |
DisclosureSEC source: 0001209191-22-006801 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,117 Read SEC document |
| February 01, 2022 Filed Feb 16, 2022 02:07 UTC Amendment | Shockwave Medical, Inc. SWAV · Entity 90374 | GrantCommon Stock | 8,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010051 · doc4a.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,867 Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 750 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · derivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,997 Underlying: Common Stock · 750 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F9 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 750 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · derivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,509 Underlying: Common Stock · 750 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F8 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 182 | $149.99 | $27,298.18 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,588 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $149.90 to $150.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $148.92 | $29,784.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,770 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $148.80 to $149.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 400 | $148.10 | $59,240.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,970 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $147.69 to $148.57. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $146.87 | $44,061.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,370 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $146.60 to $147.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $144.40 | $14,440.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,670 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The reported securities were sold at a price of $144.40. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 318 | $141.21 | $44,904.78 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,770 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.73 to $141.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 750 | $17.00 | $12,750.00 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| January 20, 2022 Filed Jan 21, 2022 23:54 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 750 | $4.03 | $3,022.50 |
DisclosureSEC source: 0001209191-22-004499 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 1,500 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · derivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,747 Underlying: Common Stock · 1,500 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F9 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 3/6/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.